Alveolar macrophages inhibit retrovirus-mediated gene transfer to airway epithelia

Human Gene Therapy

Volumn 8, Issue 9, 1997, Pages 1087-1093

  McCray Jr , Paul B ^a,c   Wang, Guoshun ^a   Kline, Joel N ^a   Zabner, Joseph ^a   Chada, Sunil ^b   Jolly, Doug J ^b   Chang, Steven M W ^b   Davidson, Beverly L ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; LIPOPOLYSACCHARIDE; LUCIFERASE;

ARTICLE; BRONCHUS MUCOSA; CONTROLLED STUDY; ENZYME ACTIVITY; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENE TRANSFER; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MACROPHAGE ACTIVATION; NORMAL HUMAN; RETROVIRUS;

BRONCHUS; UNIDENTIFIED RETROVIRUS;

EID: 16944365190     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.9-1087     Document Type: Article

References (36)

1. BAATZ, J.E., WAGNER, C.L., and ZHOU, Y. (1996). Cytokine-induced inhibition of DNA delivery to airway cells. Am. J. Respir. Crit. Care Med. 153, A114.
2. BALOUGH, K., McCUBBIN, M., WEINBERGER, M., SMITS, W., AHRENS, R., and FICK, R. (1995). The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr. Pulmonol. 20, 63-70.
3. BLAUER, F., GROSCURTH, P., SCHNEEMANN, M., SCHOEDON, G., and SCHAFFNER, A. (1995). Modulation of the antilisterial activity of human blood-derived macrophages by activating and deactivating cytokines. J. Interferon Cytokine Res. 15, 105-114.
4. BOSCH, A., McCRAY, P.B., JR., CHANG, S.M., ULICH, T.M., SIMONET, W.S., JOLLY, D.J., and DAVIDSON, B.L. (1996). Proliferation induced by keratinocyte growth factor enhances in vivo retroviral-mediated gene transfer to mouse hepatocytes. J. Clin. Invest. 98, 2683-2687.
5. BOUCHER, R.C. (1994). Human airway ion transport Part I. Am. J. Respir Crit. Care Med. 150, 271-281.
6. BOWLES, N.E., EISENSMITH, R.C., MOHUIDDIN, R., PYRON, M., and WOO, S.L.C. (1996). A simple and efficient method for the concentration and purification of recombinant retrovirus for increased hepatocyte transduction in vivo. Hum. Gene Ther. 7, 1735-1742.
7. CALANDRA, T., BERNHAGEN, J., METZ, C.N., SPIEGEL, L.A., BACHER, M., DONNELLY, T., CERAMI, A., and BUCALA, R. (1995). MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377, 68-71.
8. CLARKE, S.W., and PAVIA, D. (1991). Mucociliary clearance. In The Lung: Scientific Foundations. R.G. Crystal and J.B. West, eds. (Raven Press, New York) p. 1845.
9. COZENS, A.L., YEZZI, M.J., KUNZELMANN, K., OHRUI, T., CHIN, L., ENG, K., FINKBEINER, W.E., WIDDICOMBE, J.H., and GRUENERT, D.C. (1994). CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10, 38-47.
10. CRYSTAL, R.G. (1991). Alveolar macrophages. In The Lung: Scientific Foundations. R.G. Crystal and J.B. West, eds. (Raven Press, New York) p. 527.
11. DAHER, K.A., SELSTED, M.E., and LEHRER, R.I. (1986). Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60, 1068-1074.
12. DOHRMAN, A., TSUDA, T., ESCUDIER, E., CORDONE, M., JANY, B., GUM, J., KIM, Y., and BASBAUM, C. (1994). Distribution of lysozyme and mucin (MUC2 and MUC3) mRNA in human bronchus. Exp. Lung Res. 20, 367-380.
13. ENGELHARDT, J.F., YANKASKAS, J.R., and WILSON, J.M. (1992). In vivo retroviral gene transfer into human bronchial epithelia of xenografts. J. Clin. Invest. 90, 2598-2607.
14. FRANKEN, C., MEIJER, C.J., and DIJKMAN, J.H. (1989). Tissue distribution of antileukoprotease and lysozyme in humans. J. Histochem. Cytochem. 37, 493-498.
15. GANZ, T., and LEHRER, R.I. (1995). Defensins. Pharmacol. Ther. 66, 191-205.
16. KAVANAUGH, M.P., MILLER, D.G., ZHANG, W., LAW, W., KOZAK, S.L., KABAT, D., and MILLER, A.D. (1994). Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. USA 91, 7071-7075.
17. KHAN, T.Z., WAGENER, J.S., BOST, T., MARTINEZ, J., ACCURSO, F.J., and RICHES, D.W.H. (1995). Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151, 1075-1082.
18. KLINE, J.N., MONICK, M.M., and HUNNINGHAKE, G.W. (1992). IL-1 receptor antagonist release is regulated differently in human alveolar macrophages than in monocytes. J. Appl. Physiol. 73, 1686-1692.
19. KONSTAN, M.W., CHEN, P.W., SHERMAN, J.M., THOMASSEN, M.J., WOOD, R.E., and BOAT, T.F. (1981). Human lung lysozome: sources and properties. Am. Rev. Respir. Dis. 123, 120-124.
20. McCOY, R.D., DAVIDSON, B.L., ROESSLER, B.J., HUFFNAGLE, G.B., JANICH, S.L., LAING, T.J., and SIMON, R.H. (1995). Pulmonary inflammation induced by incomplete or inactivated adenoviral particles. Hum. Gene Ther. 6, 1553-1560.
21. McCRAY, P.B., JR., and BENTLEY, L. (1997). Human airway epithelia express a β-defensin. Am. J. Respir. Cell. Mol. Biol. 16, 343-349.
22. MILLER, A.D. (1992). Retroviral vectors. In Current Topics in Microbiology and Immunology. N. Muzyczka, ed. (Springer-Verlag, Heidelberg) p. 1.
23. O'REILLY, M.A., GAZDAR, A.F., MORRIS, R.E., and WHITSETT, J.A. (1988). Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line. Biochim. Biophys. Acta 970, 194-204.
24. OHMICHI, H., MATSUMOTO, K., and NAKAMURA, T. (1996). In vitro mitogenic action of HGF on lung epithelial cells: Pulmotrophic role in lung regeneration. Am. J. Physiol. 270, L1031-L1039.
25. OVERTURF, K., AL-DHALIMY, M., TANGUAY, R., BRANTLY, M., OU, C., FINEGOLD, M., and GROMPE, M. (1996). Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinasemia type I. Nature Genet. 12, 266-273.
26. PENNANEN, N., LAPINJOKI, S., PALANDER, A., URTTI, A., and MONKKONEN, J. (1995). Macrophage-like RAW 264 cell line and time-resolved fluoroimmunoassay (TRFIA) as tools in screening drug effects on cytokine secretion. Int. J. Immunopharmacol. 17, 475-480.
27. REYNOLDS, H.Y. (1991). Integrated host defense against infections. In The Lung: Scientific Foundations. R.G. Crystal and J.B. West, eds. (Raven Press, New York) p. 1899.
28. SHIH, C-C., STOYE, P.P., and COFFIN, J.M. (1988). Highly preferred targets for retrovirus integration. Cell 53, 531-537.
29. SMITH, J.J., TRAVIS, S.M., GREENBERG, E.P., and WELSH, M.J. (1996). Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 85, 229-236.
30. ST. GEORGE, J., PENNINGTON, S.E., KAPLAN, J.M., PETERSON, P.A., KLEINE, L.J., SMITH, A.E., and WADSWORTH, S.C. (1996). Biological response of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2. Gene Ther. 3, 103-116.
31. ULICH, T.R., YI, E.S., LONGMUIR, K., YIN, S., BILTZ, R., MORRIS, C.F., HOUSLEY, R.M., and PIERCE, G.F. (1994). Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J. Clin. Invest. 93, 1298-1306.
32. VAN ROOIJEN, N., and SANDERS, A. (1994). Liposome mediated depletion of macrophages: Mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174, 83-93.
33. WILSON, C., and KAY, M.A. (1995). Immunomodulation to enhance gene therapy. Nature Med. 1, 887-889.
34. YANG, Y., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
35. IIIB Env/Rev proteins. AIDS 9, 43-50.
36. ZSENGELLER, Z.K., WERT, S.E., HULL, W.M., HU, X., YEI, S., TRAPNELL, B.C., and WHITSETT, J.A. (1995). Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6, 457-467.